GrippeCanadaV3, Main, Exploration, bibRecord, 000772

Health benefits of universal influenza vaccination strategy.

Identifieur interne : 000772 ( Main/Exploration ); précédent : 000771; suivant : 000773

Health benefits of universal influenza vaccination strategy.

Auteurs : Cécile Viboud [États-Unis] ; Mark Miller

Source :

PLoS medicine [ 1549-1676 ] ; 2008.

RBID : pubmed:18959475

Descripteurs français

KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Grippe humaine (), Grippe humaine (immunologie), Grippe humaine (mortalité), Hospitalisation (), Humains, Jeune adulte, Mortalité (tendances), Nourrisson, Ontario, Sujet âgé, Sujet âgé de 80 ans ou plus, Vaccination (), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), États-Unis d'Amérique.
MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Grippe humaine, Vaccins antigrippaux.
- mortalité : Grippe humaine.
- tendances : Mortalité.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Grippe humaine, Hospitalisation, Humains, Jeune adulte, Nourrisson, Ontario, Sujet âgé, Sujet âgé de 80 ans ou plus, Vaccination, États-Unis d'Amérique.
Wicri :
- geographic : États-Unis.

English descriptors

KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Hospitalization (statistics & numerical data), Humans, Infant, Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (immunology), Influenza, Human (mortality), Influenza, Human (prevention & control), Middle Aged, Mortality (trends), Ontario, United States, Vaccination (methods), Vaccination (statistics & numerical data), Young Adult.
MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , immunology : Influenza Vaccines.
- geographic : Ontario, United States.
- immunology : Influenza, Human.
- methods : Vaccination.
- mortality : Influenza, Human.
- prevention & control : Influenza, Human.
- statistics & numerical data : Hospitalization, Vaccination.
- trends : Mortality.
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Humans, Infant, Middle Aged, Young Adult.

DOI: 10.1371/journal.pmed.0050216
PubMed: 18959475

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000798
to stream Main, to step Curation: 000798

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Health benefits of universal influenza vaccination strategy.</title>
<author><name sortKey="Viboud, Cecile" sort="Viboud, Cecile" uniqKey="Viboud C" first="Cécile" last="Viboud">Cécile Viboud</name>
<affiliation wicri:level="2"><nlm:affiliation>Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America. viboudc@mail.nih.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Fogarty International Center, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Miller, Mark" sort="Miller, Mark" uniqKey="Miller M" first="Mark" last="Miller">Mark Miller</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18959475</idno>
<idno type="pmid">18959475</idno>
<idno type="doi">10.1371/journal.pmed.0050216</idno>
<idno type="wicri:Area/Main/Corpus">000798</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000798</idno>
<idno type="wicri:Area/Main/Curation">000798</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000798</idno>
<idno type="wicri:Area/Main/Exploration">000798</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Health benefits of universal influenza vaccination strategy.</title>
<author><name sortKey="Viboud, Cecile" sort="Viboud, Cecile" uniqKey="Viboud C" first="Cécile" last="Viboud">Cécile Viboud</name>
<affiliation wicri:level="2"><nlm:affiliation>Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America. viboudc@mail.nih.gov</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Fogarty International Center, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Miller, Mark" sort="Miller, Mark" uniqKey="Miller M" first="Mark" last="Miller">Mark Miller</name>
</author>
</analytic>
<series><title level="j">PLoS medicine</title>
<idno type="eISSN">1549-1676</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Hospitalization (statistics & numerical data)</term>
<term>Humans</term>
<term>Infant</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (mortality)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Middle Aged</term>
<term>Mortality (trends)</term>
<term>Ontario</term>
<term>United States</term>
<term>Vaccination (methods)</term>
<term>Vaccination (statistics & numerical data)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (mortalité)</term>
<term>Hospitalisation ()</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mortalité (tendances)</term>
<term>Nourrisson</term>
<term>Ontario</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vaccination ()</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>États-Unis d'Amérique</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Ontario</term>
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Mortalité</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Mortality</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Humans</term>
<term>Infant</term>
<term>Middle Aged</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Grippe humaine</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Nourrisson</term>
<term>Ontario</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Vaccination</term>
<term>États-Unis d'Amérique</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18959475</PMID>
<DateCompleted><Year>2009</Year>
<Month>01</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1549-1676</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>5</Volume>
<Issue>10</Issue>
<PubDate><Year>2008</Year>
<Month>Oct</Month>
<Day>28</Day>
</PubDate>
</JournalIssue>
<Title>PLoS medicine</Title>
<ISOAbbreviation>PLoS Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Health benefits of universal influenza vaccination strategy.</ArticleTitle>
<Pagination><MedlinePgn>e216</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pmed.0050216</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Viboud</LastName>
<ForeName>Cécile</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America. viboudc@mail.nih.gov</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Miller</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS Med</MedlineTA>
<NlmUniqueID>101231360</NlmUniqueID>
<ISSNLinking>1549-1277</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>PLoS Med. 2008 Oct 28;5(10):e211</RefSource>
<PMID Version="1">18959473</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>10</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>1</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>10</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18959475</ArticleId>
<ArticleId IdType="pii">08-PLME-P-2494</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pmed.0050216</ArticleId>
<ArticleId IdType="pmc">PMC2573918</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Vaccine. 2006 Oct 30;24(42-43):6468-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16876293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Intern Med. 2005 Feb 14;165(3):265-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15710788</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2006 Feb 3;311(5761):615-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16456066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Epidemiol. 2006 Apr;35(2):352-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16368723</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Epidemiol. 2006 Apr;35(2):345-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16368724</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Epidemiol. 2006 Apr;35(2):337-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16368725</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2008 Oct 28;5(10):e211</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18959473</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Mol Med. 2007 Mar;13(3):94-102</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17267287</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2007 Oct;7(10):658-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17897608</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2008 Mar 25;26(14):1786-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18336965</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18685555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2008 Oct 28;5(10):e200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18959470</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><noCountry><name sortKey="Miller, Mark" sort="Miller, Mark" uniqKey="Miller M" first="Mark" last="Miller">Mark Miller</name>
</noCountry>
<country name="États-Unis"><region name="Maryland"><name sortKey="Viboud, Cecile" sort="Viboud, Cecile" uniqKey="Viboud C" first="Cécile" last="Viboud">Cécile Viboud</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000772 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000772 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:18959475
   |texte=   Health benefits of universal influenza vaccination strategy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:18959475" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020

	Corpus GrippeCanadaV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeCanadaV3

Health benefits of universal influenza vaccination strategy.

Health benefits of universal influenza vaccination strategy.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki